Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Alzheimer’s disease and related dementias

Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.

Xinyi Wang; Guangqiang Sun; Teng Feng; Jing Zhang; Xun Huang; Tao Wang; Zuoquan Xie; Xingkun Chu; Jun Yang; Huan Wang; Shuaishuai Chang; Yanxue Gong; Lingfei Ruan; Guanqun Zhang; Siyuan Yan; Wen Lian; Chen Du; Dabing Yang; Qingli Zhang; Feifei Lin; Jia Liu; Haiyan Zhang; Changrong Ge; Shifu Xiao; Jian Ding; Meiyu Geng

Originally published in Cell research · 2019-09-06

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Recently, increasing evidence has suggested the association between gut dysbiosis and Alzheimer's disease (AD) progression, yet the role of gut microbiota in AD pathogenesis remains obscure. Herein, we provide a potential mechanistic link between gut microbiota dysbiosis and neuroinflammation in AD progression. Using AD mouse models, we discovered that, during AD progression, the alteration of gut microbiota composition leads to the peripheral accumulation of phenylalanine and isoleucine, which stimulates the differentiation and proliferation of pro-inflammatory T helper 1 (Th1) cells. The brain-infiltrated peripheral Th1 immune cells are associated with the M1 microglia activation, contributing to AD-associated neuroinflammation. Importantly, the elevation of phenylalanine and isoleucine concentrations and the increase of Th1 cell frequency in the blood were also observed in two small independent cohorts of patients with mild cognitive impairment (MCI) due to AD.

Discussion

In this study, we revealed that dysbiosis of the gut microbiota is required for the infiltration of various peripheral immune cells, including CD4+ and CD8+ T cells, B cells, natural killer (NK) cells, neutrophil, dendritic cells (DCs) and monocytes, to the brain. Among them, Th1 cells were particularly noted for the close association with the M1 microglia activation during AD progression.

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?